FIELD: medicine; neurology.
SUBSTANCE: group of inventions is intended for treating a neurodegenerative disease. Method of treating a neurodegenerative disease, selected from Huntington's disease, Parkinson's disease or Alzheimer's disease in a host animal, comprises a step of administering the composition, containing an effective amount of one or more selective vasopressin V1a-receptor antagonists to a host animal. In another embodiment, using one or more selective V1a receptor antagonists vasopressin or pharmaceutically acceptable salts thereof for treating a neurodegenerative disease or disorder selected from Huntington's disease, Parkinson's disease or Alzheimer's disease in a host animal.
EFFECT: using the group of inventions provides effective treatment of a disease specified in Huntington's disease, Parkinson's disease or Alzheimer's disease.
48 cl, 18 tbl, 672 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER | 2011 |
|
RU2775783C2 |
| METHOD FOR PTSD TREATMENT | 2011 |
|
RU2623209C9 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN DAMAGE | 2018 |
|
RU2797548C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTYL PYRIMIDINE COMPOUNDS | 2013 |
|
RU2643811C2 |
| COMPOUNDS OF THIENOPYRIMIDINE | 2013 |
|
RU2637925C2 |
| COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) | 2013 |
|
RU2627661C2 |
| 5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
| SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF TUMOR NECROSIS FACTOR- LEVEL | 1997 |
|
RU2177944C2 |
| SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF DECREASE OF TUMOR NECROSIS FACTOR-α LEVEL | 1997 |
|
RU2595250C1 |
